Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon
- Posted on December 16, 2024
- By Financial Times
- 3 Views
Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon
Deal with BC Partners aims to capitalise on rising demand for off-patent versions of complex drugs
